Erratum: 3-thiomorpholin-8-oxo-8 H -acenaphtho[1,2- b ]pyrrole-9- carbonitrile (S1) based molecules as potent, dual inhibitors of b-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): Structure-based design and structure-activity relationship studies (Journal of Medicinal Chemistry (2011) 54 (1101-1105) DOI:10.1021/jm101181u);3-Thiomorpholin-8-oxo-8 h -acenaphtho[1,2- b ]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): Structure-based design and structure-activity relationship studies

Journal of Medicinal Chemistry

Volumn 54, Issue 4, 2011, Pages 1101-1105

  Zhang, Zhichao ^a   Wu, Guiye ^a   Xie, Feibo ^a,b   Song, Ting ^a   Chang, Xilong ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 THIOMORPHOLIN 8 OXO 8H ACENAPHTHO[1,2 B]PYRROLE 9 CARBONITRILE; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN MCL 1; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DRUG DESIGN; IC 50; MYELOID LEUKEMIA; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 79951847291     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401588g     Document Type: Erratum

References (21)

1. Willis, S. N.; Adams, J. M. Life in the balance: how BH3-only proteins induce apoptosis Curr. Opin. Cell. Biol. 2005, 17, 617-625 (Pubitemid 41540411)
2. Cory, S.; Huang, D. C.; Adams, J. M. The Bcl-2 family: roles in cell survival and oncogenesis Oncogene 2003, 22, 8590-8607 (Pubitemid 38028528)
3. Fleischer, A.; Rebollo, A.; Atkkib, V. BH3-only proteins: the lords of death Arch. Immunol. Ther. Exp. 2003, 51, 9-17 (Pubitemid 36522903)
4. Azmi, A. S.; Mohammad, R. M. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy J. Cell. Physiol. 2009, 218, 13-21
5. Delft, M. F. V.; Wei, A. H.; Mason, K. D.; Vandenberg, C. J.; Chen, L.; Czabotar, P. E.; Willis, S. N.; Scott., C. L.; Day, C. L.; Cory, S.; Adams, J. M.; Roberts, A. W.; Huang, D. C. S. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized Cancer Cell 2006, 10, 389-399 (Pubitemid 44711953)
6. Konopleva, M.; Contractor, R.; Tsao, T.; Samudio, I.; Ruvolo, P. P.; Kitada, S.; Deng, X.; Zhai, D.; Shi, Y. X.; Sneed, T.; Verhaegen, M.; Soengas, M.; Ruvolo, V. R.; McQueen, T.; Schober, W. D.; Watt, J. C.; Jiffar, T.; Ling, X.; Marini, F. C.; Harris, D.; Dietrich, M.; Estrov, Z.; McCubrey, J.; May, W. S.; Reed, J. C.; Andreeff, M. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia Cancer Cell 2006, 10, 375-388 (Pubitemid 44693472)
7. Kang, M. H.; Wan, Z. S.; Kang, Y. H.; Sposto, R.; Reynolds, C. P. Mechanism of synergy of N -(4-hydroxyphenyl) retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation J. Natl. Cancer. Inst. 2008, 8, 580-595
8. Warr, M. R.; Shore, G. C. Unique biology of Mcl-1: therapeutic opportunities in cancer Curr. Mol. Med. 2008, 8, 138-147 (Pubitemid 351516833)
9. Zhang, Z.; Jin, L.; Qian, X.; Wei, M.; Wang, Y.; Wang, J.; Yang, Y.; Xu, Q.; Xu, Y.; Liu, F. Novel Bcl-2 inhibitors: discovery and mechanism study of small organic apoptosis-inducing agents ChemBioChem 2007, 8, 113-121 (Pubitemid 46121578)
10. Fischer, U.; Janssen, K.; Osthoff, K. S. Cutting-edge apoptosis-based therapeutics BioDrugs 2007, 21, 273-297
11. Zhang, Z.; Song, T.; Zhang, T.; Wu, G.; Gao, J.; An, L.; Du, G. A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1. Int. J. Cancer [Online early access]. DOI: 1002/ijc.25484. Published online: May 25, 2010.
12. Qian, X.; Zhang, Z.; Xiao, Y.; Liu, F.; Lu, Z. Acenaphtho Heterocycle Compounds and the Uses in the Induce Apoptosis and Antitumor. CN Patent Appl. 200410050449.5; Sep, 15, 2004.
13. Lee, E. F.; Czabotar, P. E.; Smith, B. J.; Deshayes, K.; Zobel, K.; Colman, P. M.; Fairlie, W. D. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family Cell Death Differ. 2007, 14, 1711-1719
14. Czabotar, P. E.; Lee, E. F.; van Delft, M. F.; Day, C. L.; Smith, B. J.; Huang, D. C. S.; Douglas Fairlie, W.; Hinds, M. G.; Colman, P. M. Structural insights into the degradation of Mcl-1 induced by BH3 domains Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 6217-6222 (Pubitemid 47186075)
15. Wang, G.; Nikolovska-Coleska, Z.; Yang, C.; Wang, R.; Tang, G.; Guo, J.; Shangary, S.; Qiu, S.; Gao, W.; Yang, D.; Meagher, J.; Stuckey, J.; Krajewski, K.; Jiang, S.; Roller, P. P.; Abaan, H. O.; Tomita, Y.; Wang, S. Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins J. Med. Chem. 2006, 49, 6139-6142 (Pubitemid 44595187)
16. Etxebarria, A.; Landeta, O.; Antonsson, B.; Basañez, G. Regulation of antiapoptotic MCL-1 function by gossypol: mechanistic insights from in vitro reconstituted systems Biochem. Pharmacol. 2008, 76, 1563-1576
17. Bruncko, M.; Oost, T. K.; Belli, B. A.; Ding, H.; Joseph, M. K.; Kunzer, A.; Martineau, D.; McClellan, W. J.; Mitten, M.; Ng, S.-C.; Nimmer, P. M.; Oltersdorf, T.; Park, C.-M.; Petros, A. M.; Shoemaker, A. R.; Song, X.; Wang, X.; Wendt, M. D.; Zhang, H.; Fesik, S. W.; Rosenberg, S. H.; Elmore, S. W. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL J. Med. Chem. 2007, 50, 641-662 (Pubitemid 46332978)
18. Liu, Q.; Moldoveanu, T.; Sprules, T.; Matta-Camacho, E.; Mansur-Azzam, N.; Gehring, K. Apoptotic regulation By Mcl-1 through heterodimerization J. Biol. Chem. 2010, 285, 19615-19624
19. Tang, G.; Ding, K.; Nikolovska-Coleska, Z.; Yang, C.-Y.; Qiu, S.; Shangary, S.; Wang, R.; Guo, J.; Gao, W.; Meagher, J.; Stuckey, J.; Krajewski, K.; Jiang, S.; Roller, P. P.; Wang, S. Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins J. Med. Chem. 2007, 50, 3163-3166 (Pubitemid 47065964)
20. Lima, L. M.; Barreiro, E. J. Bioisosterism: a useful strategy for molecular modification and drug design Curr. Med. Chem. 2005, 12, 23-49 (Pubitemid 40089827)
21. Lu, Y.; Shi, T.; Wang, Y.; Yang, H.; Yan, X.; Luo, X.; Jiang, H.; Zhu, W. Halogen bondings-a novel interaction for rational drug design? J. Med. Chem. 2009, 52, 2854-2862